Touchlight

📍 Hampton, London, United Kingdom🗓 Founded 2008👥 158 employees💰 Last funded May 2021
Biotechnology Research🌐 touchlight.com
Website LinkedIn
At Touchlight we are revolutionising DNA. Our Company and technology is built on the conviction that DNA is fundamental to the future of medicine. By moving away from todays restrictive biological approaches, we have made DNA simple. Our unique dbDNA™ (or "doggybone" DNA) vector is optimised for use in advanced genetic medicines, being safer and more efficacious than conventional plasmid DNA. The platform, based on enzymatic technology, enable DNA production at unprecedented scale, speed and purity. We are leveraging our platform to develop the next generation of DNA vaccines for oncology and infectious diseases, in house and in collaboration with industry partners and academics, as well as enabling manufacture of advanced therapies (viral vectors, mRNA vaccines, and cell therapies) through our CDMO, Touchlight DNA Services. For more information please visit our website or get in touch by emailing info@touchlight.com.
2
Total investors
0
Early stage
0
Mid stage
1
Late stage
2008
Founded

Investors

2 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United Kingdom
2
Frequently asked questions
Who invested in Touchlight?
Touchlight has 2 investors on record on gritt.io and 1 late-stage investors.
When did Touchlight last raise funding?
The most recent investment in Touchlight recorded on gritt.io was in May 2021.
When was Touchlight founded?
Touchlight was founded in 2008.
What industry is Touchlight in?
Touchlight operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is Touchlight based?
Touchlight is headquartered in Hampton, London, United Kingdom.